ADVERTISEMENT

Issue Navigator

Volume 13 No. 03
Earn CME
Accepted Papers
Classifieds







Scientific Investigations

Listening to the Patient Voice in Narcolepsy: Diagnostic Delay, Disease Burden, and Treatment Efficacy

http://dx.doi.org/10.5664/jcsm.6494

Kiran Maski, MD1,2; Erin Steinhart, BS, MA2; David Williams, PhD1,2; Thomas Scammell, MD1,4; Julie Flygare, JD5; Kimberly McCleary, BA6; Monica Gow, BA7
1Harvard Medical School, Boston, MA; 2Boston Children's Hospital, Boston, MA; 4Beth Israel Deaconess Hospital, Boston, MA; 5Project Sleep, Los Angeles, CA; 6FasterCures, A Center of the Milken Institute, Washington, DC; 7Wake Up Narcolepsy, Inc, Worcester, MA

Supplemental Material

Login to view supplemental material

Study Objectives:

Describe common symptoms, comorbidities, functional limitations, and treatment responsiveness among patients with narcolepsy. Investigate the effect of pediatric onset of narcolepsy symptoms on time to diagnosis of narcolepsy and presence of comorbid depression.

Methods:

Cross-sectional survey of 1,699 people in the United States with self-reported diagnosis of narcolepsy. We utilized mixed-methods data analyses to report study findings.

Results:

Most participants reported receiving a diagnosis of narcolepsy more than 1 y after symptom onset. We found that the strongest predictor of this delayed diagnosis was pediatric onset of symptoms (odds ratio = 2.4, p < 0.0005). Depression was the most common comorbidity but we detected no association with pediatric onset of narcolepsy symptoms. Overall, participants reported that fatigue and cognitive difficulties were their most burdensome symptoms in addition to sleepiness and cataplexy. The majority of participants reported residual daytime fatigue and/or sleepiness despite treatment. Most participants reported they could not perform at work or school as well as they would like because of narcolepsy symptoms.

Conclusions:

This study provides unique insight into the narcolepsy disease experience. The study quantifies the problem of diagnostic delay for narcolepsy patients in the United States and highlights that symptoms are more likely to be missed if they develop before 18 y of age. These results suggest that narcolepsy awareness efforts should be aimed at parents, pediatric health care providers, school professionals, and children/adolescents themselves. Disease burden is high because of problems with fatigue, cognition, and persistence of residual symptoms despite treatment.

Citation:

Maski K, Steinhart E, Williams D, Scammell T, Flygare J, McCleary K, Gow M. Listening to the patient voice in narcolepsy: diagnostic delay, disease burden and treatment efficacy. J Clin Sleep Med. 2017;13(3):419–425.




Please login to continue reading the full article

Subscribers to JCSM get full access to current and past issues of the JCSM.

Login to JCSM

Not a subscriber?

Join the American Academy of Sleep Medicine and receive a subscription to JCSM with your membership